Related Experiment Video
Updated: Jan 19, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons
Markus Riessland1, Benjamin Kolisnyk1, Tae Wan Kim2
1Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, 1230 York Ave., New York, NY 10065, USA.
Abstract:
Cellular senescence is a mechanism used by mitotic cells to prevent uncontrolled cell division. As senescent cells persist in tissues, they cause local inflammation and are harmful to surrounding cells, contributing to aging. Generally, neurodegenerative diseases, such as Parkinson's, are disorders of aging. The contribution of cellular senescence to neurodegeneration is still unclear. SATB1 is a DNA binding protein associated with Parkinson's disease. We report that SATB1 prevents cellular senescence in post-mitotic dopaminergic neurons. Loss of SATB1 causes activation of a cellular senescence transcriptional program in dopamine neurons both in human stem cell-derived dopaminergic neurons and in mice. We observed phenotypes that are central to cellular senescence in SATB1 knockout dopamine neurons in vitro and in vivo. Moreover, we found that SATB1 directly represses expression of the pro-senescence factor p21 in dopaminergic neurons. Our data implicate senescence of dopamine neurons as a contributing factor in the pathology of Parkinson's disease.
Insights
SATB1 protein prevents cellular senescence in dopamine neurons, a key factor in Parkinson's disease. Loss of SATB1 activates senescence, contributing to neurodegeneration and aging.
Area of Science:
- Neuroscience
- Cell Biology
- Aging Research
Background:
- Cellular senescence, a state of irreversible cell cycle arrest, contributes to aging and age-related diseases.
- Neurodegenerative diseases like Parkinson's disease are associated with aging, but the role of cellular senescence in neurodegeneration remains unclear.
- SATB1, a DNA-binding protein, has been linked to Parkinson's disease.
Purpose of the Study:
- To investigate the role of SATB1 in cellular senescence of dopaminergic neurons.
- To determine if SATB1 dysfunction contributes to Parkinson's disease pathology.
Main Methods:
- Investigated SATB1's role in cellular senescence using human stem cell-derived dopaminergic neurons and mouse models.
- Analyzed gene expression and cellular phenotypes in SATB1 knockout models.
- Examined the direct regulation of senescence-associated genes, such as p21, by SATB1.
Main Results:
- SATB1 was found to prevent cellular senescence in post-mitotic dopaminergic neurons.
- Loss of SATB1 led to the activation of a senescence transcriptional program in dopaminergic neurons.
- Phenotypes characteristic of cellular senescence were observed in SATB1-deficient dopaminergic neurons in vitro and in vivo.
- SATB1 was shown to directly repress the expression of the pro-senescence factor p21.
Conclusions:
- SATB1 plays a critical role in preventing senescence in dopaminergic neurons.
- Senescence of dopaminergic neurons, driven by SATB1 loss, is implicated as a contributing factor to Parkinson's disease pathology.
- These findings highlight a novel mechanism linking cellular senescence to neurodegeneration in Parkinson's disease.
Related Concept Videos
Abnormal Proliferation
Satellite Stem Cells and Muscular Dystrophy
Replicative Cell Senescence
Inhibition of Cdk Activity
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

